BioAge Labs, Inc. (BIOA) Investors Suffering Losses Encouraged to Learn About Their Rights and Potential Recovery
New York, NY – If you have invested in BioAge Labs, Inc. (NASDAQ: BIOA) and have experienced significant losses, you may be entitled to compensation under the federal securities laws. A securities class-action lawsuit has been filed against BioAge Labs, Inc. and certain of its officers and directors, alleging that they violated the Securities Exchange Act of 1934 by making false and misleading statements to the market.
Details of the Lawsuit
The complaint, filed in the United States District Court for the Southern District of New York, alleges that BioAge Labs and its executives made false and misleading statements regarding the company’s financial condition and business prospects. Specifically, the complaint alleges that the defendants failed to disclose material information regarding the company’s financial condition, including its revenue growth, cash flow, and customer base.
Impact on Individual Investors
If you purchased or otherwise acquired BioAge Labs securities between February 1, 2023, and November 1, 2024, you may be able to recover your losses through the class action. The lawsuit seeks to represent a large group of investors who have been affected by the defendants’ alleged securities law violations. The exact amount of damages that may be recoverable will depend on the individual circumstances of each investor.
Impact on the World
The BioAge Labs lawsuit is a reminder that investors must be vigilant in monitoring the companies they invest in, particularly those in the biotech industry. The lawsuit also highlights the importance of accurate and timely disclosures by publicly traded companies, as misrepresentations and omissions can have significant consequences for both investors and the broader financial markets.
Next Steps for Investors
If you invested in BioAge Labs during the relevant period and believe you have suffered losses as a result of the defendants’ alleged securities law violations, you may be eligible to participate in the class action. To learn more about your rights and potential recovery, you can submit your information using the form below or contact Joseph E. Levi, Esq. directly at (212) 363-7500 or [email protected].
*Disclosure: This press release may be considered attorney advertising. Past results do not guarantee or predict future performance. Investors are encouraged to consult with their financial advisor and legal counsel before making any investment decision.
- If you invested in BioAge Labs between February 1, 2023, and November 1, 2024, you may be able to recover your losses through the class action lawsuit.
- The lawsuit alleges that BioAge Labs and certain executives made false and misleading statements regarding the company’s financial condition and business prospects.
- The lawsuit seeks to represent a large group of investors who have been affected by the defendants’ alleged securities law violations.
- Individual damages will depend on the specific circumstances of each investor.
- Investors are encouraged to consult with their financial advisor and legal counsel before making any investment decisions.
The outcome of this lawsuit could have significant implications for BioAge Labs and its investors. It is important for investors to stay informed about the progress of the case and any potential developments. We will continue to monitor the situation and provide updates as they become available.
Contact Information:
Joseph E. Levi, Esq.
Zamansky LLC
200 Park Avenue, 19th Floor
New York, NY 10166
(212) 363-7500
About Zamansky LLC:
Zamansky LLC is a New York City-based law firm specializing in securities and investment fraud, as well as consumer class actions. The firm represents both individual and institutional investors in securities arbitration and litigation proceedings in state and federal courts throughout the United States.
This press release may be reprinted in its entirety or excerpts may be used, provided that the credit is given to Zamansky LLC and a link to www.zamansky.com is included.
